4.0 percent of seniors had received dementia diagnosis in 2022
Jun 13, 2024
An increase in the percentage with a dementia diagnosis was seen with increasing age; a decrease was seen with an increasing education level.
The 5-Cog paradigm improves diagnosis, management of dementia
Jun 11, 2024
A threefold improvement was seen in dementia care actions with the 5-Cog paradigm, a culturally adept cognitive detection tool.
Preeclampsia linked to increased risk for young-onset dementia
May 31, 2024
An even higher risk for young-onset dementia was seen for preeclampsia before 34 weeks of gestation or superimposed on chronic hypertension.
Inappropriate diagnosis of pneumonia common in hospitalized adults
Mar 27, 2024
Inappropriate diagnosis is common, especially in older patients and those with dementia or an altered mental status on presentation.
American Stroke Association, Feb. 7-9
Feb 20, 2024
The conference featured presentations that emphasized basic, clinical and translational medicine and provided insight into the prevention, management and treatment of stroke.
Risk for adverse outcomes increased with antipsychotic use in dementia
Apr 19, 2024
Risks increased for stroke, venous thromboembolism, myocardial infarction, heart failure, fracture, pneumonia and acute kidney injury.
American Academy of Neurology, April 13-18
Apr 23, 2024
The annual meeting of the American Academy of Neurology was held this year from April 13 to 18 in Denver, drawing participants from around the world, including clinicians, academicians, allied health professionals,...
Lower risk for MCI, dementia seen with cognitively stimulating occupations
Apr 17, 2024
Participants in a high versus low routine task intensity group had a higher risk for mild cognitive impairment and dementia.
AAN: Dementia more common with essential tremor than in the general population
Mar 08, 2024
Dementia rates, however, were lower than a comparison cohort of people with Parkinson’s disease.
Burden of neurologic diagnoses lower after COVID-19 versus flu
Mar 20, 2024
Postinfection incident neurologic diagnoses were observed in 2.79 and 4.91% of the COVID-19 and influenza cohorts, respectively.